Cargando…

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

BACKGROUND: Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although previous transcriptomic and proteomic studies have reported subtype-related heterogeneity, the intracase transcriptomic alterations between metaplast...

Descripción completa

Detalles Bibliográficos
Autores principales: Lien, Huang-Chun, Hsu, Chia-Lang, Lu, Yen-Shen, Chen, Tom Wei-Wu, Chen, I.-Chun, Li, Yu-Chia, Huang, Chiun-Sheng, Cheng, Ann-Lii, Lin, Ching-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883935/
https://www.ncbi.nlm.nih.gov/pubmed/36707876
http://dx.doi.org/10.1186/s13058-023-01608-5
_version_ 1784879610506248192
author Lien, Huang-Chun
Hsu, Chia-Lang
Lu, Yen-Shen
Chen, Tom Wei-Wu
Chen, I.-Chun
Li, Yu-Chia
Huang, Chiun-Sheng
Cheng, Ann-Lii
Lin, Ching-Hung
author_facet Lien, Huang-Chun
Hsu, Chia-Lang
Lu, Yen-Shen
Chen, Tom Wei-Wu
Chen, I.-Chun
Li, Yu-Chia
Huang, Chiun-Sheng
Cheng, Ann-Lii
Lin, Ching-Hung
author_sort Lien, Huang-Chun
collection PubMed
description BACKGROUND: Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although previous transcriptomic and proteomic studies have reported subtype-related heterogeneity, the intracase transcriptomic alterations between metaplastic components and paired NST components, which are critical for understanding the pathogenesis underlying the metaplastic processes, remain unclear. METHODS: Fifty-nine NST components and paired metaplastic components (spindle carcinomatous [SPS], matrix-producing, rhabdoid [RHA], and squamous carcinomatous [SQC] components) were microdissected from specimens obtained from 27 patients with MpBC for gene expression profiling using the NanoString Breast Cancer 360 Panel on a NanoString nCounter FLEX platform. BC360-defined signatures were scored using nSolver software. RESULTS: Hierarchical clustering and principal component analysis revealed a heterogeneous gene expression profile (GEP) corresponding to the NST components, but the GEP of metaplastic components exhibited subtype dependence. Compared with the paired NST components, the SPS components demonstrated the upregulation of genes related to stem cells and epithelial–mesenchymal transition and displayed enrichment in claudin-low and macrophage signatures. Despite certain overlaps in the enriched functions and signatures between the RHA and SPS components, the specific differentially expressed genes differed. We observed the RHA-specific upregulation of genes associated with vascular endothelial growth factor signaling. The chondroid matrix-producing components demonstrated the upregulation of hypoxia-related genes and the downregulation of the immune-related MHC2 signature and the TIGIT gene. In the SQC components, TGF-β and genes associated with cell adhesion were upregulated. The differentially expressed genes among metaplastic components in the 22 MpBC cases with one or predominantly one metaplastic component clustered paired NST samples into clusters with correlation with their associated metaplastic types. These genes could be used to separate the 31 metaplastic components according to respective metaplastic types with an accuracy of 74.2%, suggesting that intrinsic signatures of NST may determine paired metaplastic type. Finally, the EMT activity and stem cell traits in the NST components were correlated with specimens displaying lymph node metastasis. CONCLUSIONS: We presented the distinct transcriptomic alterations underlying metaplasia into specific metaplastic components in MpBCs, which contributes to the understanding of the pathogenesis underlying morphologically distinct metaplasia in MpBCs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-023-01608-5.
format Online
Article
Text
id pubmed-9883935
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98839352023-01-29 Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma Lien, Huang-Chun Hsu, Chia-Lang Lu, Yen-Shen Chen, Tom Wei-Wu Chen, I.-Chun Li, Yu-Chia Huang, Chiun-Sheng Cheng, Ann-Lii Lin, Ching-Hung Breast Cancer Res Research BACKGROUND: Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although previous transcriptomic and proteomic studies have reported subtype-related heterogeneity, the intracase transcriptomic alterations between metaplastic components and paired NST components, which are critical for understanding the pathogenesis underlying the metaplastic processes, remain unclear. METHODS: Fifty-nine NST components and paired metaplastic components (spindle carcinomatous [SPS], matrix-producing, rhabdoid [RHA], and squamous carcinomatous [SQC] components) were microdissected from specimens obtained from 27 patients with MpBC for gene expression profiling using the NanoString Breast Cancer 360 Panel on a NanoString nCounter FLEX platform. BC360-defined signatures were scored using nSolver software. RESULTS: Hierarchical clustering and principal component analysis revealed a heterogeneous gene expression profile (GEP) corresponding to the NST components, but the GEP of metaplastic components exhibited subtype dependence. Compared with the paired NST components, the SPS components demonstrated the upregulation of genes related to stem cells and epithelial–mesenchymal transition and displayed enrichment in claudin-low and macrophage signatures. Despite certain overlaps in the enriched functions and signatures between the RHA and SPS components, the specific differentially expressed genes differed. We observed the RHA-specific upregulation of genes associated with vascular endothelial growth factor signaling. The chondroid matrix-producing components demonstrated the upregulation of hypoxia-related genes and the downregulation of the immune-related MHC2 signature and the TIGIT gene. In the SQC components, TGF-β and genes associated with cell adhesion were upregulated. The differentially expressed genes among metaplastic components in the 22 MpBC cases with one or predominantly one metaplastic component clustered paired NST samples into clusters with correlation with their associated metaplastic types. These genes could be used to separate the 31 metaplastic components according to respective metaplastic types with an accuracy of 74.2%, suggesting that intrinsic signatures of NST may determine paired metaplastic type. Finally, the EMT activity and stem cell traits in the NST components were correlated with specimens displaying lymph node metastasis. CONCLUSIONS: We presented the distinct transcriptomic alterations underlying metaplasia into specific metaplastic components in MpBCs, which contributes to the understanding of the pathogenesis underlying morphologically distinct metaplasia in MpBCs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-023-01608-5. BioMed Central 2023-01-27 2023 /pmc/articles/PMC9883935/ /pubmed/36707876 http://dx.doi.org/10.1186/s13058-023-01608-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lien, Huang-Chun
Hsu, Chia-Lang
Lu, Yen-Shen
Chen, Tom Wei-Wu
Chen, I.-Chun
Li, Yu-Chia
Huang, Chiun-Sheng
Cheng, Ann-Lii
Lin, Ching-Hung
Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title_full Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title_fullStr Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title_full_unstemmed Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title_short Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
title_sort transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883935/
https://www.ncbi.nlm.nih.gov/pubmed/36707876
http://dx.doi.org/10.1186/s13058-023-01608-5
work_keys_str_mv AT lienhuangchun transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT hsuchialang transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT luyenshen transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT chentomweiwu transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT chenichun transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT liyuchia transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT huangchiunsheng transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT chengannlii transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma
AT linchinghung transcriptomicalterationsunderlyingmetaplasiaintospecificmetaplasticcomponentsinmetaplasticbreastcarcinoma